LendingTree, Inc. (TREE) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001434621 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $313.4M | $9.6M | $0.68 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $327.3M | $17.3M | $1.22 | Filing |
| Dec 31, 2025 | Mar 2, 2026 | $319.7M | $144.3M | $10.32 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $307.8M | $10.2M | $0.73 | Filing |
| Jun 30, 2025 | Jul 23, 2025 | $250.1M | $8.9M | $0.65 | Filing |
| Mar 31, 2025 | May 1, 2025 | $239.7M | $-12.4M | $-0.92 | Filing |
| Dec 31, 2024 | Mar 5, 2025 | $261.5M | $7.2M | $0.54 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $260.8M | $-58.0M | $-4.34 | Filing |
What would LendingTree, Inc. have to report for its valuation to change?
At $25.39, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -30.0% a year, to $2.17. On that path the next quarter needs diluted EPS near $0.51, against $0.73 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -30.0% | -30.0% |
| EPS needed in final year | $2.17 | $2.17 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. TREE goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.